Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Perfluorohexyloctane Ophthalmic Solution in Patients with Dry Eye Disease Undergoing Cataract Surgery: A Prospective Multicenter Study.
Journal: Ophthalmology and therapy
Published: October 09, 2025
Efficacy and Safety of Preservative-Free Bimatoprost 0.01% Gel in Patients with Open-Angle Glaucoma and Ocular Hypertension: Results from Two Phase III Randomized Trials.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: October 08, 2025
Expert Opinion to Optimize Clinical Outcomes of Bimatoprost Intracameral Implant Treatment.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: May 03, 2025
Double-Masked, Dose-Response, Vehicle-Controlled Study of VVN461 Ophthalmic Solution in Postoperative Ocular Inflammation.
Journal: Ophthalmology science
Published: January 28, 2025
Negative Pressure Application by the Ocular Pressure Adjusting Pump to Lower Intraocular Pressure in Normal-Tension Glaucoma: HERCULES Study.
Journal: American journal of ophthalmology
Published: January 22, 2025
Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in Dry Eye Disease: A Prospective, Open-Label, Multicenter Study.
Journal: Ophthalmology and therapy
Published: November 11, 2024
The Effect of Eyedrop Size on Pupillary Dilation Using the Nanodropper Bottle Adapter.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: November 03, 2024
Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 04, 2024
Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: August 16, 2024
Sepetaprost 0.002% Noninferiority vs. Timolol 0.5% in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: ANGEL-2.
Journal: Ophthalmology. Glaucoma
Published: July 31, 2024
Early diagnostics and interventional glaucoma.
Journal: Therapeutic advances in ophthalmology
Published: May 23, 2024
Last Updated: 09/26/2026